<DOC>
	<DOC>NCT03083951</DOC>
	<brief_summary>A randomized, controlled clinical trial comparing lymphadenectomy with extended inferior mesenteric artery ligation (complete mesocolon excision: which includes lymphoma tissue from the origin of the inferior mesenteric vein) with conventional locoregional lymphadenectomy in patients undergoing laparoscopic sigmoidectomy for sigmoid cancer.</brief_summary>
	<brief_title>Complete Mesocolon Excision vs Locoregional Lymphadenectomy in Sigmoid Colon Cancer (CMELL)</brief_title>
	<detailed_description />
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Colonic Neoplasms</mesh_term>
	<mesh_term>Sigmoid Neoplasms</mesh_term>
	<criteria>Patients undergoing programmed surgery for laparoscopic sigmoid colon cancer. Age â‰¥ 18 years and &lt;80 years. Histology of adenocarcinoma or adenoma without chemotherapy or neoadjuvant radiotherapy. Any T, any N, M0. Intention of resection R0. Informed consent signed by the patient and the investigator. Colorectal tumor with histology other than adenocarcinoma or adenoma. Colon cancer located in the right colon, transverse, splenic or nonsigmoid left colon. Metastatic disease (M1). History of colorectal cancer surgery, different from a local excision. Inflammatory bowel disease with anatomopathological confirmation. Patients with psychiatric illness, addiction or any disorder that pmpedes the understanding of informed consent. Inability to read or understand any of the languages of the informed consent (Catalan, Spanish). Another synchronous malignant disease. Emergency surgery.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Complete mesocolon excision</keyword>
	<keyword>Sigmoid cancer</keyword>
	<keyword>Colorectal cancer</keyword>
</DOC>